吸烟对HPV相关口咽鳞癌分期特异性生存的影响
本研究回顾性分析2009-2017年单中心HPV阳性口咽癌患者,按吸烟包年分为0-9和≥10组,比较各分期总生存。结果示I、II期吸烟与否无统计学差异,III期吸烟者5年OS更差(38% vs. 76%,p<0.05)。提示>10包年吸烟可能对晚期HPV阳性口咽癌生存有负面影响。
要点
- HPV阳性口咽癌I、II期吸烟者与不吸烟者5年OS无显著差异。
- III期HPV阳性口咽癌吸烟者5年OS显著低于不吸烟者(38% vs. 76%,p<0.05)。
- >10包年吸烟状态或需纳入晚期HPV阳性口咽癌风险分层。
核心结论
- 大于10包年吸烟状态可能对晚期HPV阳性口咽癌生存有负面影响,但对早期疾病无显著影响。
研究设计与样本
- 单中心回顾性病历回顾研究,纳入2009-2017年HPV阳性口咽癌患者,吸烟史二分为0-9和≥10包年,采用Kaplan-Meier法比较总生存。
主要发现
- I期和II期HPV阳性口咽癌中,吸烟者与不吸烟者5年总生存无统计学差异。
- III期HPV阳性口咽癌中,吸烟者5年总生存显著低于不吸烟者(38% vs. 76%,p<0.05)。
临床怎么用
- 对晚期(III期)HPV阳性口咽癌患者,应评估>10包年吸烟史以辅助风险分层。
- 早期HPV阳性口咽癌中吸烟状态对生存的区分作用不显著,治疗决策仍需综合其他因素。
局限性
- 单中心回顾性研究,样本量未报告,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The American Joint Committee on Cancer (AJCC) released a new staging system for human papilloma virus (HPV) positive oropharyngeal cancer (OPC) in their eighth edition. The role of smoking in HPV positive oropharyngeal cancer remains controversial and is not factored into the updated staging system. METHODS: Single institutional, retrospective chart review of patients with HPV positive OPC from 2009 to 2017 was completed. Dichotomized smoking data were collected into 0-9 and ≥10 pack-year histories. Kaplan-Meier survival curves compared overall survival (OS) for smokers and nonsmokers. RESULTS: Five-year OS was not statistically different in stage I or stage II HPV positive OPC comparing nonsmokers versus smokers, but worse in stage III smokers (38% vs. 76%, p < 0.05). CONCLUSION: Greater than 10 pack-year smoking status may negatively affect survival in late stage HPV positive OPC but not in early stage disease. HPV positive smokers may require additional risk stratification.
引用
- Horwich P, Gundale A, Patin S, et al. Impact of smoking on stage-specific survival in human papilloma virus-associated oropharyngeal squamous cell carcinoma. Head Neck. 2021. PMID: 34002904. doi:10.1002/hed.26745
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。